Series C - Exicure
Investment Firm
Overview
Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.
Announced Date
Jun 17, 2014
Funding Type
Series C
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 Patrick Ryan |
 Bill Gates |
 Craig Mundie |
Round Details and Background
Exicure raised $13600000 on 2014-06-17 in Series C
Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.
Company Funding History
12
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 17, 2014 |  Series C - Exicure | 4 | - | 13.6M |
| Dec 01, 2009 | Series A - Exicure | - | 2.5M | |
| Jul 31, 2013 | Series B - Exicure | 1 | - | undefined |
| Dec 21, 2011 | Series B - Exicure | 5 | - | 5.4M |
Recent Activity
There is no recent news or activity for this profile.